Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details)

v3.23.1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 29, 2021
Nov. 24, 2021
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Jun. 21, 2022
Jan. 02, 2022
Sep. 17, 2021
Jun. 30, 2021
Jan. 31, 2021
Stockholders’ Equity (Details) [Line Items]                    
Common shares authorized     500,000,000 500,000,000            
Description of authorized capital stock       The authorized capital stock is divided into: (i) 495,000,000 shares of Common Stock having a par value of $0.0001 per share and (ii) 5,000,000 shares of preferred stock having a par value of $0.0001 per share.            
Common stock, shares issued     26,043,406 26,043,406 23,008,371 3,260,870        
Common stock, shares outstanding     26,043,406 26,043,406 23,008,371          
Common stock, voting rights       one            
Increase to equal percentage         3.00%          
Aggregate of stock options       800,000 600,000          
Total shares     1,966,483 1,966,483            
Potential issuances shares       466,483            
Price per shares (in Dollars per share)               $ 0.01   $ 1.6
Shares issued     2,700,000 395,625            
Aggregate proceeds received (in Dollars)       $ 633,000            
Additional shares         153,652          
Gross proceeds (in Dollars)         $ 7,000,000          
Issued shares 8,680,000                  
Warrants to purchase 8,680,000                  
Cash fee   9.00%                
Accountable expenses (in Dollars)   $ 70,000                
Offering price per (in Dollars per share) $ 3.5                  
Aggregate gross proceeds (in Dollars) $ 30,400,000                  
Underwriter discounts and fees (in Dollars) $ 27,000,000                  
Purchased shares of common stock     3,205,282              
Price per share (in Dollars per share)     $ 1.0003              
Certain fees and expenses (in Dollars)     $ 698,000              
Settlement agreements (in Dollars)       $ 300,000            
Fair value (in Dollars)         288,000          
Vested shares       66,667            
Stock based compensation expense (in Dollars)       $ 440,000 142,000          
Restricted Common Stock       150,000            
Additional-paid-in capital and compensation expenses (in Dollars)         $ 152,000          
Common Stock [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Common stock, shares issued     26,043,406 26,043,406 23,008,371 3,260,870        
Common stock, shares outstanding     26,043,406 26,043,406 23,008,371          
Restricted Common Stock         150,000          
Minimum [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Number of shares issuance             685,751      
Investors election percentage       4.99%            
Maximum [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Number of shares issuance             1,966,483      
Investors election percentage       9.99%            
2021 Stock Incentive Plan [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Initial number of common shares         1,280,732          
Second Private Placement [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Price per shares (in Dollars per share)                 $ 2.4  
Shares issued       239,969            
Aggregate proceeds received (in Dollars)       $ 576,000            
IPO [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Aggregate shares         4,800,000          
Public Warrants [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Aggregate shares         1,120,000          
Common Stock [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Common stock, shares issued     1,500,000 1,500,000            
Common stock, shares outstanding     1,500,000 1,500,000            
Restricted Stock Units (RSUs) [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Stock based compensation expense (in Dollars)       $ 96,000 $ 3,000          
Remaining unamortized compensation expense (in Dollars)     $ 189,000 189,000            
Restricted Stock [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Stock based compensation expense (in Dollars)       $ 15,000 $ 45,000          
Restricted Common Stock       279,447 25,000          
Total grant date fair value vested (in Dollars)       $ 282,000            
Restricted Stock [Member] | Common Stock [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Stock based compensation expense (in Dollars)       $ 282,000            
Restricted Common Stock       279,447            
Restricted Stock [Member] | Warrant [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Restricted Common Stock         25,000          
Total grant date fair value vested (in Dollars)         $ 60,000          
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Shares issued         200,000          
2022 Common Stock Transactions [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Shares issued       3,260,870            
November 2021 Private Placement [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Issued shares   8,680,000                
Warrants to purchase   8,680,000                
Purchase price (in Dollars per share)   $ 3.5                
Warrants term   5 years                
Exercise per share (in Dollars per share)   $ 3.5                
Cash fee   1.00%